In fact, DAO enzyme activity is considered a biomarker for diagnosing and applying new treatments for fibromyalgia (Dr Healthcare, 2022), and elevated histamine in the blood due to DAO deficiency in HIT patients can be used as a diagnostic tool but can be expensive and laborious (Zhao et al., 2022). This evidence concerns the gene DAO and fibromyalgia.